MigreLief

Precautions re: Pregnant or Nursing or Prescription Medications

This product is not recommended during pregnancy and breast feeding, or for children under two years of age.

Precautions re: Children

This product is not recommended during pregnancy and breast feeding, or for children under two years of age.

Precautions re: All Other

Consult a heath care provider prior to use if you are taking blood thinners.

Precautions re: Allergies

May cause allergies in those allergic to the Astercae/composite (daisy, ragweed) family.

Formulation re: Does NOT Contain

Does not contain: Yeast, milk, corn, wheat, gluten, soy, salt, artificial flavorings or preservatives.

General Statements: All Other Content

Safety sealed for your protection

General Statements: All Other Content

Patent #6,068,999

Formula re: Contains

with Puracol

Formula re: Contains

~ Feverfew ~ Magnesium ~ Riboflavin

FDA Statement of Identity

Dietary Supplement

Precautions re: All Other

This product is intended to provide support of cerebrovascular tone and does not provide immediate pain relief.

Brand IP Statement(s) re: (c), (TM), (SM)

Puracol is a proprietary combination of whole leaf feverfew containing naturally occurring phytochemicals and unique feverfew extract containing parthenolides.

FDA Disclaimer Statement

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

General: Product/Version Code

REV. 0214

Suggested/Recommended/Usage/Directions

Suggested Use: As a dietary supplement take one tablet twice daily or as directed by a health professional.

General Statements: All Other Content

Benefits to cerebrovascular tone may be noticed in 4-12 weeks.

Precautions re: Children

Warning: Keep out of reach of children.